| Literature DB >> 23576562 |
Luis E Arias-Romero1, Olga Villamar-Cruz, Min Huang, Klaus P Hoeflich, Jonathan Chernoff.
Abstract
p21-Activated kinase-1 (Pak1) is frequently upregulated in human breast cancer and is required for transformation of mammary epithelial cells by ErbB2. Here, we show that loss of Pak1, but not the closely related Pak2, leads to diminished expression of β-catenin and its target genes. In MMTV-ErbB2 transgenic mice, loss of Pak1 prolonged survival, and mammary tissues of such mice showed loss of β-catenin. Expression of a β-catenin mutant bearing a phospho-mimetic mutation at Ser 675, a specific Pak1 phosphorylation site, restored transformation to ErbB2-positive, Pak1-deficient mammary epithelial cells. Mice bearing xenografts of ErbB2-positive breast cancer cells showed tumor regression when treated with small-molecule inhibitors of Pak or β-catenin, and combined inhibition by both agents was synergistic. These data delineate a signaling pathway from ErbB2 to Pak to β-catenin that is required for efficient transformation of mammary epithelial cells, and suggest new therapeutic strategies in ErbB2-positive breast cancer. ©2013 AACR.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23576562 PMCID: PMC3687032 DOI: 10.1158/0008-5472.CAN-12-4453
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701